Bookimed

Cover Block

Name	Bookimed
Tagline	Medical tourism marketplace connecting patients to global hospitals and doctors
Headquarters	Kyiv, Ukraine
Founded	2014
Stage	Seed
Business Model	Marketplace
Industry	Healthtech
Technology	Software (Non-AI)
Geography	Eastern Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Seed (total disclosed ~$500,000)

Links

• Website: https://us-uk.bookimed.com
• LinkedIn: https://www.linkedin.com/company/bookimed

What an Investor Needs First

Bookimed operates a global medical tourism marketplace, connecting patients with hospitals and doctors across borders, a business that has scaled to an estimated $20 million in annual revenue with minimal disclosed outside capital [PitchBook, 2026]. Founded in 2014 by Evgeniy Kozlov and Eugene Khotianov, the company has built a network of over 1,200 medical centers and 3,300 doctors across 50 countries, serving more than 920,000 patients [Tracxn, 2025]. The platform's wedge is providing transparent access to affordable, high-quality healthcare options, with 24/7 support throughout the treatment journey. The founding team, based in Kyiv, has navigated the complexities of international healthcare logistics to achieve this scale. The company's financial profile is notable, with a single, small seed round of $500,000 in 2017 [CB Insights] reported against the current revenue run-rate, suggesting a potentially bootstrapped or highly capital-efficient path to its current position.

Data Accuracy: YELLOW -- Core operational metrics are cited from third-party aggregators; revenue figures are reported but not independently verified.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	Marketplace
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	Eastern Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	Seed (total disclosed ~$500,000)

Inside the Company

Bookimed was founded in 2014 in Kyiv, Ukraine by Evgeniy Kozlov and Eugene Khotianov [Tracxn, 2025]. The company operates as a digital marketplace for medical tourism, connecting patients with international hospitals and doctors. Its founding narrative centers on providing access to affordable, high-quality healthcare across borders, a proposition that has scaled to a network spanning 50 countries.

Key operational milestones are tied to network growth and patient volume. By 2025, the platform reported partnerships with over 1,200 medical centers and more than 3,300 doctors [Tracxn, 2025]. The company also claims to have served over 920,000 patients through its marketplace [Tracxn, 2025]. A single seed funding round of $500,000 was closed in December 2017, with AVentures Capital listed as an investor [CB Insights].

Headcount estimates vary across sources, ranging from 68 to 200 employees [Crunchbase, PitchBook, ZoomInfo, Owler]. The company's headquarters remains in Kyiv, which introduces a specific operational and geopolitical context for a globally focused business.

Data Accuracy: YELLOW -- Founding details confirmed by Tracxn and Crunchbase; operational milestones and employee counts are reported by multiple sources but with conflicting figures.

Under the Hood

Bookimed's product is a global medical tourism marketplace, a software layer that connects patients seeking treatment with hospitals and clinics abroad. The platform's core function is to facilitate discovery, comparison, and booking, acting as a centralized intermediary for a complex, high-stakes transaction. According to the company, this includes providing transparent quotes, coordinating travel logistics, and offering 24/7 support throughout the treatment journey [Bookimed].

The marketplace's scale is its primary technological asset. Public sources report a network of over 1,200 medical centers and more than 3,300 doctors across 50 countries [Tracxn, 2025]. This inventory, spanning specialties from oncology to orthopedics, is presented to patients who can browse and compare options based on factors like cost, location, and doctor qualifications. The company claims to have served over 920,000 patients through this platform [Tracxn, 2025]. The underlying technology stack is not detailed publicly, but the operational model suggests significant investment in a multi-language customer service team, a database of medical providers, and a booking/coordination system.

Data Accuracy: YELLOW -- Scale metrics are reported by third-party aggregators but not independently verified by major press. Core service description is confirmed by the company's own website.

Market Research

The medical tourism market represents a structural response to persistent healthcare cost inflation and access disparities, creating a durable, if fragmented, global opportunity. Pre-pandemic estimates from McKinsey & Company and Patients Beyond Borders placed the global market for cross-border patient travel between $45 billion and $72 billion annually [McKinsey & Company] [Patients Beyond Borders]. The serviceable addressable market for a digital marketplace like Bookimed is narrower, focused on patients who actively research and book procedures online.

Demand is propelled by several converging tailwinds. Cost arbitrage remains the primary driver, with procedures in popular destinations like Turkey, India, and Thailand often costing 50-80% less than in the US or Western Europe [Patients Beyond Borders]. Reduced wait times for elective surgeries in public health systems push patients to seek faster alternatives abroad. Furthermore, specialization and quality convergence are significant factors. Many destination hospitals now hold international accreditations (e.g., Joint Commission International) and employ surgeons trained in Western institutions, narrowing the perceived quality gap [McKinsey & Company].

Metric	Value
Cumulative Patients Served	920,000+
Monthly Website Visitors	300,000
Partner Medical Centers	1,200+
Partner Doctors	3,300+
Geographic Reach	50 countries

Data Accuracy: YELLOW -- Market sizing is inferred from analogous reports; company traction metrics are sourced from third-party aggregators but lack independent verification.

Competition and Substitutes

Bookimed operates in a fragmented global market for medical tourism, where its primary competition comes from other digital marketplaces rather than traditional travel agencies or individual hospitals.

Company	Positioning	Stage / Funding	Notable Differentiator
Bookimed	Global medical tourism marketplace across 50+ countries and 1,200+ centers.	Seed (~$500k disclosed). Revenue $20.3M (2025, est).	Broad geographic and specialty coverage; claims over 920k patients served.
Medigo	Marketplace for medical procedures abroad, part of the DocPlanner group.	Acquired (2019). Backed by DocPlanner's ~$1B+ valuation.	Integration with a larger doctor appointment platform network in Europe.
PlacidWay	US-based medical tourism platform founded in 2006.	Privately held, funding undisclosed.	Longevity in the market; strong focus on North American outbound patients.
Vaidam Health	India-focused platform for international patients seeking treatment in India.	Series A ($5M, 2021).	Deep specialization and network within the Indian hospital ecosystem.
Qunomedical	Germany-based digital health platform for finding and booking doctors globally.	Venture-backed (Series A 2018).	Emphasis on vetted quality and patient care coordination, with a European base.

Data Accuracy: YELLOW -- Competitor profiles and funding stages are sourced from Crunchbase, but specific differentiators and market positions are inferred from company positioning. Bookimed's scale metrics are from Tracxn but lack independent verification.

Opportunity

If Bookimed can consolidate its position as the primary gateway for a growing global medical tourism market, the company represents a rare asset: a capital-efficient, scaled marketplace with a clear path to becoming the category-defining platform. The headline opportunity is for Bookimed to become the default global search and booking engine for elective cross-border healthcare.

Scenario	What happens	Catalyst
Regional Hub Dominance	Bookimed becomes the dominant platform for patients traveling from Eastern Europe and the Middle East to key medical destinations in Turkey, Germany, and India.	A strategic partnership or white-label agreement with a major national health insurer or employer in a source region.
Vertical Specialization	The platform evolves from a generalist marketplace to the definitive destination for 2-3 high-value, complex procedure categories.	Launch of a dedicated "Clinical Excellence" program featuring vetted centers of excellence.
B2B Infrastructure Play	Bookimed's matching and logistics engine is licensed as an API to hospitals, governments, and other aggregators.	The product team packages the backend coordination, quality vetting, and patient support services as a standalone SaaS offering.

Data Accuracy: YELLOW -- Key scale metrics (revenue, patients served) are cited by single sources (PitchBook, Tracxn) without independent public corroboration.

Sources

1. [PitchBook, 2026] Bookimed 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/222869-53
2. [Tracxn, 2025] Bookimed - 2025 Company Profile, Team & Funding | https://tracxn.com/d/companies/bookimed/__mL_IP1EEtAXf4MZ9rHOQ8evc-bSPXOz0NPrbw6A2754
3. [CB Insights] Bookimed - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/bookimed
4. [Crunchbase] Bookimed - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/bookimed-com
5. [Bookimed] About us - Bookimed | https://us-uk.bookimed.com/about/
6. [McKinsey & Company] McKinsey & Company |
7. [Patients Beyond Borders] Patients Beyond Borders |
8. [ZoomInfo] Bookimed - Overview, News & Similar companies | https://www.zoominfo.com/c/bookimed-co/368652316
9. [Owler] Owler |
10. [Trustpilot] US-UK.Bookimed.com is rated "Excellent" with 4.6 / 5 on Trustpilot | https://www.trustpilot.com/review/www.bookimed.com